Prognostic value of histological type in stage IV ovarian carcinoma: A retrospective analysis of 223 patients

M. Mizuno, H. Kajiyama, K. Shibata, K. Mizuno, M. Kawai, T. Nagasaka, F. Kikkawa

研究成果: Article査読

17 被引用数 (Scopus)


Background:Patients with FIGO stage IV epithelial ovarian carcinoma have a poor but non-uniform prognosis. This study aimed to compare the survival of patients with serous or endometrioid tumours (S/E) and clear cell or mucinous tumours (non-S/E).Methods:Data for 223 patients who underwent surgery between 1987 and 2010 and were diagnosed by centralized pathology review and were retrospectively analysed. The patients included 169 with S/E tumours and 54 with non-S/E tumours.Results:The median overall survivals (OSs) of the S/E and non-S/E groups were 3.1 and 0.9 years, respectively (P<0.001). Six patients (2.7%), all with non-S/E tumours, died within 6 weeks after the initial surgery. Multivariate OS analysis revealed that performance status, residual tumor, metastatic sites, no debulking surgery, and non-S/E tumours were independent poor prognostic factors. For patients with non-S/E tumours, prognosis was more favourable for single-organ metastasis, except for liver or distant lymph nodes, no residual tumor, and resection of metastasis (median OS: 4.1, 4.6, and 2.6 years, respectively).Conclusions:In stage IV ovarian carcinoma, non-S/E tumours are associated with a significantly poorer prognosis and higher rates of early mortality compared to S/E tumours. Therefore, careful management and development of new strategies are required.

ジャーナルBritish Journal of Cancer
出版ステータスPublished - 14-04-2015

All Science Journal Classification (ASJC) codes

  • 腫瘍学
  • 癌研究


「Prognostic value of histological type in stage IV ovarian carcinoma: A retrospective analysis of 223 patients」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。